Cargando…
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER)
AIM: When selecting treatments for type 2 diabetes (T2D), it is important to consider not only efficacy and safety, but also other treatment attributes that have an impact on patient preference. The objective of this study was to examine preference between injection devices used for two weekly GLP‐1...
Autores principales: | Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Coyne, Karin S., Wullenweber, Paula K., Cutts, Katelyn N., Jordan, Jessica B., Wang, Qianqian, Yu, Maria, Currie, Brooke M., Malley, Karen G., Ishak, K. Jack, Hietpas, Ryan T., García‐Pérez, Luis‐Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064885/ https://www.ncbi.nlm.nih.gov/pubmed/31646727 http://dx.doi.org/10.1111/dom.13902 |
Ejemplares similares
-
Validity and analysis of the Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Boye, Kristina S., et al.
Publicado: (2020) -
Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Matza, Louis S., et al.
Publicado: (2018) -
Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
por: Pleil, Andreas M, et al.
Publicado: (2012) -
The Pen
Publicado: (1949) -
Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments
por: Boye, Kristina S., et al.
Publicado: (2021)